| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vistagen Therapeutics, Inc. (VTGN) has 12 insiders with recent SEC Form 4 filings, including 10 buys and 2 sells. VTGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 75.0K | $45.8K | - | |
| CFO | 75.0K | $45.8K | - | |
| CEO | 71.3K | $43.5K | - | |
| COO | 56.2K | $34.3K | - | |
| Other | 56.2K | $34.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2023 | Commodore Capital LP | 10% Owner | Buy | 775,756 | $23.15 | $17,961,078.67 | +97.1% | -74.0% | -75.5% | |
| Aug 18, 2022 | Gin Jerry B | Director | Buy | 200,000 | $0.18 | $35,740.00 | New | -33.8% | -17.9% | |
| Aug 17, 2022 | Adler Reid G. | Chief Legal Officer | Buy | 300,000 | $0.17 | $50,910.00 | +866.3% | -17.6% | -4.4% | |
| Aug 17, 2022 | Singh Shawn | Chief Executive Officer | Buy | 600,000 | $0.17 | $103,200.00 | +2,287% | -17.6% | -4.4% | |
| Jul 12, 2022 | Venrock Healthcare Capital Partners Ii, L.P. | 10% Owner | Sell | 60,000 | $0.89 | $53,400.00 | -0.3% | -85.2% | -93.4% | |
| Sep 7, 2021 | Dotson Jerrold Duane | VP, CFO And Secretary | Sell | 30,000 | $3.13 | $93,750.00 | -29.2% | -46.2% | -94.7% | |
| Aug 17, 2021 | Snodgrass H. Ralph | Pres./ Chief Scientific Officer | Buy | 3,750 | $2.73 | $10,237.50 | +12.1% | -20.7% | -92.9% | |
| Aug 21, 2020 | Saxe Jon S | Director | Buy | 30,000 | $0.69 | $20,700.00 | +150.0% | - | - | |
| Nov 20, 2019 | Snodgrass H. Ralph | Pres./ Chief Scientific Officer | Buy | 15,000 | $0.34 | $5,100.00 | New | - | - | |
| Mar 14, 2019 | Saxe Jon S | Director | Buy | 20,000 | $1.26 | $25,287.59 | +165.6% | - | - |